Background The optimal antithrombotic (antiplatelet or anticoagulant) treatment of patients
undergoing extracranial carotid artery interventions is a subject of debate. The aim of this …

Background Transcarotid artery revascularization (TCAR) was approved by the Food and
Drug Administration in 2015 for patients with carotid artery stenosis. However, no …

Considerable variability exists in the way that health-care providers treat patients with giant
cell arteritis in Latin America, with patients commonly exposed to excessive amounts of …

BACKGROUND: Effectiveness of carotid procedures (surgery and stenting) in patients with
asymptomatic carotid artery stenosis (ACAS) depends on the absolute risk reduction that …

Background Carotid endarterectomy (CEA) is associated with lower risk of perioperative
stroke compared with transfemoral carotid artery stenting (TFCAS) in the treatment of carotid …

BACKGROUND: In 2015, the FDA approved transcarotid artery revascularization (TCAR) as
an alternative to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF …

Background In-hospital stroke (IHS) has been associated with worse outcomes than out-of-
hospital stroke (OHS) due to delays in diagnosis and treatment. A paucity of studies exists …

Discussion Many investigators have evaluated the cognitive outcomes of carotid
interventions. Ongoing research suggests that carotid revascularization exerts a beneficial …

Despite the publication of several national/international guidelines, the optimal management
of patients with asymptomatic carotid stenosis (AsxCS) remains controversial. This article …

Asymptomatic carotid stenosis has been shown to be associated with progressive
neurocognitive decline, but the effects of carotid endarterectomy (CEA) on this are not well …